This week, the University of Michigan’s Zell Lurie Institute announced a new program called Michigan Academy for the Development of Entrepreneurs (MADE), which aims to help business owners in developing nations to grow and thrive.
The program, which has been established... Read more »
With 2018 around the corner, this was a week to look ahead. At Xconomy, we zeroed in on several clinical trials that could become major stories in the life sciences. Other healthcare milestones are on the way, too.
The FDA will... Read more »
How do you disrupt an industry that markets itself as the embodiment of “forever?”
You bring it back to basics, says Lindsay Reinsmith, co-founder of Ada Diamonds, an online retailer of jewelry with lab-made gemstones in San Francisco. “Science is on... Read more »
On Monday we posted the first part of our look at what should be some of 2018’s most important clinical data, including trials for lung cancer, heart disease, melanoma, Alzheimer’s disease, rare blood disorders, and more. With part two, we’re... Read more »
Austin—Seven years ago, Scott Hanson was a student at University of Michigan who was hoping to raise a few hundred thousand dollars for Ambiq Micro, his fledgling startup that aimed to make low-powered microcontrollers.
Today, Ambiq is headquartered in... Read more »
Author, investor, and AOL co-founder Steve Case today announced a new $150 million venture fund aimed at pumping investment capital into tech companies in so-called flyover states. Contributing to the fund is an impressive group of some of the most successful... Read more »
Many of biotech’s biggest stories in 2017 followed the highly anticipated data from clinical studies. There were monumental successes, like the first-ever approval of a genetically modified living cell therapy, the first FDA application for a gene therapy or a... Read more »
A pair of migraine drugs made a splash in biotech news this week with published data suggesting that they can reduce the frequency of headaches.
These drugs still await an FDA decision, and their impact on patients over the long term... Read more »
We still live in the early days of autonomous vehicles. We’re toddlers, technologically speaking, and our algorithms are still learning to walk, er, drive.
That’s the impression you get from reading the various recaps of an autonomous car test run that... Read more »
Genesis Innovation Group, a Holland, MI-based collective of venture investors focused on early-stage medical device startups, is raising a new $10 million fund called Cultivate(MD) Capital Fund I.
Genesis is not the typical venture capital firm. In an interview earlier this... Read more »
If Wednesday’s hearing for Health and Human Services Secretary Nominee Alex Azar is any indication, reining in drug prices and insurance premiums are the policy priorities that will guide Congress’s interaction with the department under a new leader.
For the better... Read more »
On Oct. 30, I received the usual weekly email from TechShop, the makerspace just outside of Detroit in Allen Park, MI, informing me of upcoming events and membership deals. Just two weeks later, an email from TechShop CEO Dan Woods... Read more »
David “Stock” Baird is a songwriter, producer, and entrepreneur who spends a lot of time thinking of new and better ways for independent musicians to get paid for their work. He found a way to connect his passions by creating Selocial... Read more »